General Cancer News
Top Stories
Breast Cancer Risk Amplified By Additional Genes In Combination With Damaged BRCA Genes
POSTED: April 18, 2008PHILADELPHIA -- Many women with a faulty breast cancer gene could be at greater risk of the disease due to extra risk-amplifying genes, according to research published this month in the American Journal of Human Genetics. Researchers at the University of Pennsylvania School of Medicine join an international consortium of research groups that looked a...
An Alternative To Surgery For Treating Skin Cancer
POSTED: April 18, 2008DANBURY, Conn. -- May is National Skin Cancer Awareness Month. TOPEX, Inc. located in Danbury, CT is helping to fight this disease with a low energy or superficial x-ray therapy system specially designed for this treatment procedure. This new system provides an alternative to surgery for treating basal cell and squamous cell carcinomas, especial...
HPV, Periodontitis Work In Tandem To Increase Risk Of Tongue Cancer
POSTED: April 18, 2008Persons with periodontitis who also are infected with human papillomavirus (HPV) are at increased risk of developing tongue cancer, new research conducted at the University at Buffalo School of Dental Medicine has shown. Periodontitis is a chronic inflammatory disease that destroys connective tissue and bone supporting the teeth. It has been associated ...
Chemicals In Plastic Worry U.S. Agency
POSTED: April 18, 2008WASHINGTON -- A draft report from a U.S. government agency said exposure to bisphenol A in plastic may pose serious health risks. The National Institutes of Health's National Toxicology Program urged further study of possible links between the chemical and breast cancer, prostate cancer, early puberty in girls and hyperactivity, The Washingto...
AACR Presentation Illustrates Broad Potential Of Antisoma's AS1411 In Blood Cancers
POSTED: April 18, 2008LONDON and SAN DIEGO, CA -- Antisoma plc announces that new preclinical data on its anti-nucleolin aptamer drug AS1411 are presented today at the American Association for Cancer Research (AACR) meeting in San Diego, CA. The presentation shows that AS1411 killed cells from a variety of blood cancer cell lines, including leukemias, lymphomas and ...
Blocking The Effect Of Inflammation-causing Cells Lowered Prostate Cancer Cells Invasion
POSTED: April 18, 2008Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting the communication between the cancer cells and other cells t...
Double Binding Sites On Tumor Target May Provide Future Combination Therapy
POSTED: April 18, 2008Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer. An increasing number of therapies targeting tum...
New Study Shows Dermytol Produces Pronounced Decrease In Malignant Melanoma Tumor Volume
POSTED: April 18, 2008SAN DIEGO, CA. -- A new study presented at the Experimental Biology Annual Meeting shows that a proprietary blend extracted from canola, Dermytol , produces a pronounced reduction of malignant melanoma cell growth. Dermytol, a proprietary compound developed by KGK Synergize Inc., a biotechnology company in Ontario Canada, is designed to protect skin cel...
Milatuzumab May Enhance Efficacies Of Therapeutics For Multiple Myeloma In Preclinical Studies
POSTED: April 15, 2008SAN DIEGO -- Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced today that milatuzumab, its humanized anti-CD74 antibody, showed in animal models promising therapeutic activity for multiple myeloma when used alone or in combination with bortezomib and ...
Marrow Stem Cell Gene Is Identified
POSTED: April 15, 2008BOSTON -- U.S. scientists say they have identified a gene responsible for the division and movement of marrow-derived, blood-forming stem cells. The researchers at the Joslin Diabetes Center said their discovery could have major implications for the future of bone marrow and blood cell transplantation. Every year, some 45,000 people undergo ...
